Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 287, Issue 3 31-3, 2004, Pages

  Fratz, Sohrab ^a,b   Meyrick, Barbara ^c   Ovadia, Boaz ^b   Johengen, Michael J ^b   Reinhartz, Olaf ^b   Azakie, Anthony ^b   Ross, Greg ^b   Fitzgerald, Robert ^b   Oishi, Peter ^b   Hess, John ^a   Black, Stephen M ^d   Fineman, Jeffrey R ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MONTANA   (United States)

Author keywords

Congenital heart defect; Pulmonary heart disease

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; PREPROENDOTHELIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOPULMONARY SEPTAL DEFECT; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; EXPERIMENTAL MODEL; FEMALE; HEART RIGHT ATRIUM PRESSURE; IMMUNOHISTOCHEMISTRY; LAMB; LUNG ALVEOLUS; LUNG BLOOD FLOW; LUNG HEMODYNAMICS; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; THICKNESS; TISSUE LEVEL; TISSUE STRUCTURE;

ANIMALS; ASPARTIC ENDOPEPTIDASES; CYCLIC GMP; ENDOTHELIN-1; FEMALE; HYPERTENSION, PULMONARY; METALLOENDOPEPTIDASES; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; PREGNANCY; PULMONARY CIRCULATION; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; SHEEP;

EID: 4143065708     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00093.2004     Document Type: Article

References (30)

1. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, and Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97-106, 2000.
2. Black SM, Bekker JM, McMullan DM, Parry AJ, Ovadia B, Reinhartz O, Lakshminrushimha S, Mata-Greenwood E, Steinhorn RH, and Fineman JR. Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow. Pediatr Res 52: 233-244, 2002.
3. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
4. Black SM, Sanchez LS, Mata-Greenwood E, Bekker JM, Steinhorn RH, and Fineman JR. sGC and PDE5 are elevated in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 281: L1051-L1057, 2001.
5. Bush PA, Gonzalez NE, and Ignarro LJ. Biosynthesis of nitric oxide and citrulline from L-arginine by constitutive nitric oxide synthase present in rabbit corpus cavernosum. Biochem Biophys Res Commun 186: 308-314, 1992.
6. DiCarlo VS, Chen SJ, Meng QC, Durand J, Yano M, Chen YF, and Oparil S. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am J Physiol Lung Cell Mol Physiol 269: L690-L697, 1995.
7. Fineman JR, Soifer SJ, and Heymann MA. Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol 57: 115-134, 1995.
8. Fratz S, Geiger R, Kresse H, Roemer G, Hennig M, Sebening W, and Hess J. Pulmonary blood pressure, not flow, is associated with net endothelin-1 production in the lungs of patients with congenital heart disease and normal pulmonary vascular resistance. J Thorac Cardiovasc Surg 126: 1724-1729, 2003.
9. Furchgott RF and Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
10. Giaid A and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 333: 214-221, 1995.
11. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, and Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739, 1993.
12. Goto K. Basic and therapeutic relevance of endothelin-mediated regulation. Biol Pharm Bull 24: 1219-1230, 2001.
13. Guembe L and Villaro AC. Immunohistochemical mapping of endothelin in the developing and adult mouse lung. J Histochem Cytochem 49: 1301-1309, 2001.
14. Hassoun PM, Thappa V, Landman MJ, and Fanburg BL. Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med 199: 165-170, 1992.
15. Hill NS, Warburton RR, Pietras L, and Klinger JR. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats. J Appl Physiol 83: 1209-1215, 1997.
16. Hoffman JI, Rudolph AM, and Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64: 873-877, 1981.
17. Ignasiak DP, McClanahan TB, Saganek LJ, Potoczak RE, Hallak H, and Gallagher KP. Effects of endothelin ETA receptor antagonism with PD 156707 on hemodynamics and renal vascular resistance in rabbits. Eur J Pharmacol 321: 295-300, 1997.
18. Nguyen QT, Colombo F, Rouleau JL, Dupuis J, and Calderone A. LU135252, an endothelin(A) receptor antagonist did not prevent pulmonary vascular remodelling or lung fibrosis in a rat model of myocardial infarction. Br J Pharmacol 130: 1525-1530, 2000.
19. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, and Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58: 1107-1122, 1978.
20. Reddy VM, Meyrick B, Wong J, Khoor A, Liddicoat JR, Hanley FL, and Fineman JR. In utero placement of aortopulmonary shunts. A model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs. Circulation 92: 606-613, 1995.
21. Reid LM. The pulmonary circulation: remodeling in growth and disease. The 1978 J. Burns Amberson lecture. Am Rev Respir Dis 119: 531-546, 1979.
22. Reynolds EE, Keiser JA, Haleen SJ, Walker DM, Olszewski B, Schroeder RL, Taylor DG, Hwang O, Welch KM, and Flynn MA. Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. J Pharmacol Exp Ther 273: 1410-1417, 1995.
23. Rondelet B, Kerbaul F, Motte S, van Beneden R, Remmelink M, Brimioulle S, McEntee K, Wauthy P, Salmon I, Ketelslegers JM, and Naeije R. Bosentan for the prevention of overcirculation-induced experimental pulmonary arterial hypertension. Circulation 107: 1329-1335, 2003.
24. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, and Simonneau G. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346: 896-903, 2002.
25. Vincent JA, Ross RD, Kassab J, Hsu JM, and Pinsky WW. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am J Cardiol 71: 1204-1207, 1993.
26. Wessel A, Buchhorn R, and Bursch J. Circulatory failure in children with left-to-right shunt in the framework of congenital heart defects: pathophysiology and therapeutic results. Klin Padiatr 212: 53-59, 2000.
27. Wong J, Reddy VM, Hendricks-Munoz K, Liddicoat JR, Gerrets R, and Fineman JR. Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 269: H1965-H1972, 1995.
28. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
29. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, and Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84: 2280-2285, 1991.
30. Zeballos GA, Bernstein RD, Thompson CI, Forfia PR, Seyedi N, Shen W, Kaminski PM, Wolin MS, and Hintze TH. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 91: 2982-2988, 1995.